bg
S

Spero Therapeutics (SPRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Spero Therapeutics (SPRO)

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more

  • USD0.58
  • USD0.64
  • USD0.57
  • USD1.69
  • 5.10%
  • 48M
  • 81.46k
  • 110.27k
  • 36M
  • 0.51
  • -63.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.